| MRSN Stock Yearly Return 2019 Table | ||||||||||||||||||||||||||||||
MRSN average annual return is presented with the assumption of reinvestments of any dividends on ex-date. |
| Average Annual Return Benchmarks |
|
Compare MRSN average annual return versus benchmarks: S&P Average Annual Return Dow Average Annual Return Nasdaq 100 Average Annual Return Russell 2000 Average Annual Return Gold Average Annual Return 10 Year Treasury Average Annual Return |
| MRSN Share Performance |
| MRSN Stock Yearly Return 2019 Chart | |||
Also see: • MRSN stock yearly return 2020 • MRSN YTD return • MRSN average annual return 10 years | |||
| About Mersana Therapeutics Inc |
| Mersana Therapeutics is a clinical stage biopharmaceutical company focused on developing antibody drug conjugates (ADCs) for cancer patients. Co.'s platforms which include Dolaflexin and Dolasynthen, delivering its DolaLock payload, as well as Immunosynthen, delivering a stimulator of interferon genes agonist. Co.'s product candidates include upifitamab rilsodotin (UpRi, XMT-1536), which is a Dolaflexin ADC in a Phase 1 proof-of-concept clinical trial in patients with tumors likely to express NaPi2b, an antigen expressed in ovarian cancer and non-small cell lung cancer, adenocarcinoma; and XMT-1592 through dose escalation, targeting NaPi2b-expressing tumors. The MRSN stock yearly return is shown above.
The yearly return on the MRSN stock yearly return page and across the coverage universe of our site, is a measure of the annual return over the calendar year 2019 for the given stock. When performing this calculation it is important to factor in dividends, because a financial instrument's annual return is more than just the change in price if that instrument pays a dividend or coupon. One way to factor dividends into the return is simply to count them as cash — we don't do that here. Instead, our website aims to empower investors by performing the MRSN annual return calculation with any dividends reinvested as applicable (on ex-dates). |
| MRSN Current Stock Quote |
Get Free SEC filing alerts for MRSN:
MRSN SEC Filing Email Alerts Service 
|
| Video: Don't Forget Dividends in Annual Return! | |
|
| Yearly Return Peers |
| Mersana Therapeutics (MRSN) is categorized under the Healthcare sector; to help you further research average annual return performance across stocks, below are some other companies in the same sector:
MRTX Average Annual Return |
Video: Don't Forget Dividends in Average Annual Return!